The VIC Investor Network features high-impact, high-return life science companies, with experienced done-it-before management teams, co-investment with experienced investors, and more.
VIN addresses the primary challenges of angel investing in science and technology-driven innovation
Co-investment on same terms with larger investors and built-in investment safeguards
Investments may be made as low as $5k per invested company allowing more investments and portfolio diversification
Secondary market for VIN shares gives members opportunity for liquidity prior to portfolio exits
Turnkey support through all stages of portfolio companies’ development.
Incubate high-potential ideas for future VIC portfolio companies.
Equity funding for proof-of-concept through commercial product roll-out.
Series A/B funding to reach major value-enhancing milestones.
Companies built from the ground up based on high impact technologies exclusively licensed from top research institutions around the world. View All Companies